Journal profile · Respiratory System

Journal of Aerosol Medicine and Pulmonary Drug Delivery

ISSN 1941-2711 · eISSN 1941-2703 · Mary Ann Liebert Inc. · UNITED STATES · Quarterly · Founded 2008

Journal of Aerosol Medicine and Pulmonary Drug Delivery: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.16; hybrid open access; review over 12 weeks (community reports); community-reported acceptance: fairly easy; 43 articles in 2025; indexed in SCIE and Scopus.

Impact factor2.16Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review timeover 12 weeksCommunity average
APC—No source gives fee information
AcceptanceFairly easyCommunity average
Articles per year432025 · OpenAlex count

Scope

Aims, scope and focus

Journal of Aerosol Medicine and Pulmonary Drug Delivery is published by Mary Ann Liebert Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Inhalation and Respiratory Drug Delivery, Asthma and respiratory diseases and Cystic Fibrosis Research Advances, together about 57.1% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)

Sage, a leading independent academic publisher, has acquired Mary Ann Liebert, Inc., a global media company known for publishing over 100 peer-reviewed journals in biotechnology, life sciences, clinical medicine, public health, and engineering. The journals will be available on the Sage Journals platform beginning 1 January 2026. A dual access period will run from 1 January through 30 March 2026

From the journal's Aims & Scope

Research area (LetPub): Respiratory System

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Inhalation and Respiratory Drug DeliveryMedicine37%
  2. Asthma and respiratory diseasesMedicine14.4%
  3. Cystic Fibrosis Research AdvancesMedicine5.7%
  4. Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine4.8%
  5. Neonatal Respiratory Health ResearchMedicine4.4%
  6. Respiratory Support and MechanismsMedicine3.9%
  7. Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics3.9%
  8. Nosocomial Infections in ICUMedicine2.8%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRespiratory SystemZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRespiratory SystemZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRespiratory SystemZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
2.16LetPub ·
CiteScore 2026-06
3.9LetPub ·
SJR 2026-06
0.48LetPub ·
SNIP 2026-06
0.76LetPub ·
h-index
61LetPub ·
h-index
75OpenAlex ·
i10-index
485OpenAlex ·
2-year mean citedness
2.45OpenAlex ·
Self-citation rate
4.5%LetPub ·
Share of gold OA articles
16.33%LetPub ·

Volume

Articles per year
30LetPub ·

Articles by year OpenAlex count · 865 in total · the current year is incomplete

YearArticlesOpen accessCitations
202629410
2025431958
20243928204
20234310243
2022318273
20213713279

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
over 12 weeksLetPub ·
Average acceptance (community reports)
Fairly easyLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Mary Ann Liebert Inc.
Country or region
UNITED STATES
Language
English
Frequency
Quarterly
Founded
2008
ISSN
1941-2711
Electronic ISSN
1941-2703
Official links

FAQ

Frequently asked questions about Journal of Aerosol Medicine and Pulmonary Drug Delivery

What CAS zone is Journal of Aerosol Medicine and Pulmonary Drug Delivery in?

In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Aerosol Medicine and Pulmonary Drug Delivery is in Zone 4 of Medicine, and in Zone 4 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Journal of Aerosol Medicine and Pulmonary Drug Delivery?

The latest impact factor listed by LetPub is 2.16; CiteScore 3.9, h-index 75.

How long does peer review take at Journal of Aerosol Medicine and Pulmonary Drug Delivery?

Authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Journal of Aerosol Medicine and Pulmonary Drug Delivery?

According to LetPub and DOAJ records, Journal of Aerosol Medicine and Pulmonary Drug Delivery is indexed in SCIE and Scopus.

Is Journal of Aerosol Medicine and Pulmonary Drug Delivery open access, and what is the APC?

Journal of Aerosol Medicine and Pulmonary Drug Delivery is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .